Obesity, Metabolic Syndrome, and ‘Difficult-to-Treat’ Psoriatic Arthritis: Is Inflammation Only Half the Story?

Obesity, Metabolic Syndrome, and ‘Difficult-to-Treat’ Psoriatic Arthritis Is Inflammation Only Half the Story Review Abstract Psoriatic arthritis (PsA) is a chronic, immune mediated inflammatory musculoskeletal disease that affects a substantial proportion of individuals with psoriasis. Characterized by peripheral arthritis, enthesitis, dactylitis, axial involvement, and progressive joint damage, PsA is associated

Devastating Impact Of Rheumatoid Arthritis Fatigue

Devastating Impact Of Rheumatoid Arthritis Fatigue Overview Fatigue is a prevalent symptom that significantly impacts the outcomes and functioning of individuals with rheumatoid arthritis (RA). This study aimed to evaluate fatigue in RA patients using two different scales, while also validating their consistency and thoroughly examining the fatigue-related risk factors.    In this case-control

Corticosteroids In Osteoarthritis Therapy: Scarce Evidence For A Superior Drug And Dose

Corticosteroids In Osteoarthritis Therapy: Scarce Evidence For A Superior Drug And Dose Overview ​​The objective of this study was to measure and compare the clinical significance of various intra-articular corticosteroids (CS) in treating osteoarthritis (OA). In October 2023, a comprehensive search was conducted using PubMed, Cochrane, and Web of Science databases, adhering to

Biologic Therapy Tapering In Inflammatory Arthritis

Biologic Therapy Tapering In Inflammatory Arthritis Overview The aim of this study was to identify predictors of successful biologic tapering in patients with inflammatory arthritis, using baseline characteristics from the BIODOPT trial. The trial included adult patients with rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who had been on a stable biologic

Rheumatoid Arthritis: Monitoring Disease With Neutrophil-To-Monocyte Ratio

Rheumatoid Arthritis: Monitoring Disease With Neutrophil-To-Monocyte Ratio Overview A recent case-control study conducted in Ibb City, Republic of Yemen, focused on identifying effective hematological markers for monitoring disease activity in patients with chronic rheumatoid arthritis (RA). This autoimmune disease is characterized by chronic inflammation. The study explored three novel inflammatory markers: neutrophil-monocyte

Obesity, Metabolic Syndrome, and ‘Difficult-to-Treat’ Psoriatic Arthritis: Is Inflammation Only Half the Story?